在固体瘤中使用瘤病毒和CAR-T细胞治疗
Eleonora Ponterio1,2, Tobias Longin Haas2,3, Ruggero De Maria2,4
1Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy.
Frontiers in immunology
|November 14, 2024
概括
化学抗原受体 (CAR) -T细胞疗法在与型病毒结合时,对固体瘤有望. 这种组合增强了T细胞的透,克服了瘤诱导的免疫抑制,改善了癌症治疗.
科学领域:
- 免疫治疗是一种免疫疗法.
- 瘤病毒学 瘤病毒学
- 癌症生物学 癌症生物学
背景情况:
- 使用仿真抗原受体 (CAR) -T细胞的采用免疫疗法是一种有前途的癌症治疗方法,目前主要在血液恶性瘤中有效.
- 固体瘤对CAR-T细胞治疗具有独特的挑战,包括瘤透率有限和瘤微环境中的免疫抑制.
- 瘤病毒 (OV) 选择性地破坏癌细胞,并可以刺激抗瘤免疫反应.
研究的目的:
- 审查最近在CAR-T细胞和型病毒设计方面的进展.
- 探索将CAR-T细胞疗法与型病毒疗法结合用于治疗固体癌症的潜力.
- 为突出克服瘤微环境中介免疫抑制的策略.
主要方法:
- 关于CAR-T细胞治疗和型病毒的当前文献的综述.
- 分析瘤微环境中的宿主病毒相互作用.
- 结合治疗策略的讨论.
主要成果:
- 卡特-T细胞疗法在固体瘤中表现出有限的疗效,原因是瘤透和免疫逃避等挑战.
- 瘤病毒可以通过改善瘤透和减少局部免疫抑制来增强CAR-T细胞疗法.
- 了解宿主病毒相互作用是优化组合疗法的关键.
结论:
- 将CAR-T细胞与瘤性病毒结合起来,为增强对固体瘤的抗瘤免疫提供了一个有希望的策略.
- 这种结合方法有可能克服当前CAR-T细胞治疗固体癌症的局限性.
- 对优化型病毒和CAR-T细胞设计的进一步研究对于临床成功至关重要.
相关概念视频
Tumor Immunotherapy
480
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
480
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Cancer Vaccines
340
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
340


